PHG-R Stock Overview
Operates hospitals in Thailand. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 2/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
Patrangsit Healthcare Group Public Company Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ฿15.80 |
52 Week High | ฿17.50 |
52 Week Low | ฿11.80 |
Beta | 0 |
11 Month Change | -1.25% |
3 Month Change | -0.63% |
1 Year Change | 28.46% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -3.07% |
Recent News & Updates
Recent updates
Shareholder Returns
PHG-R | TH Healthcare | TH Market | |
---|---|---|---|
7D | -1.3% | -1.3% | 0.3% |
1Y | 28.5% | -9.3% | 3.2% |
Return vs Industry: PHG-R exceeded the TH Healthcare industry which returned -9.3% over the past year.
Return vs Market: PHG-R exceeded the TH Market which returned 3.2% over the past year.
Price Volatility
PHG-R volatility | |
---|---|
PHG-R Average Weekly Movement | 3.9% |
Healthcare Industry Average Movement | 4.3% |
Market Average Movement | 4.6% |
10% most volatile stocks in TH Market | 10.0% |
10% least volatile stocks in TH Market | 2.4% |
Stable Share Price: PHG-R has not had significant price volatility in the past 3 months compared to the TH market.
Volatility Over Time: PHG-R's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1984 | n/a | Ronnachit Yaemsaard | www.patrangsit.com |
Patrangsit Healthcare Group Public Company Limited operates hospitals in Thailand. The company offers physical therapy, pediatric, eye, psychiatry, child and adolescent psychiatry, dental, orthopedic surgery, chest and heart surgery, general surgery, urology surgery, neurosurgery, obstetrics and gynecology, ear, nose, throat, internal medicine, gastrointestinal and liver medicine, neuro medicine, pulmonary and respiratory, cardiology, hematology, skin, and hemodialysis services. It also provides pediatric dental, skin, gastrointestinal tract and liver, nervous systems, pulmonary and respiratory, allergy, heart disease, and kidney disease, as well as child development services; and health check-up services, radiology and laboratory, men’s health services, gastrointestinal tract endoscopy, chemotherapy, and women oncology services.
Patrangsit Healthcare Group Public Company Limited Fundamentals Summary
PHG-R fundamental statistics | |
---|---|
Market cap | ฿4.74b |
Earnings (TTM) | ฿294.77m |
Revenue (TTM) | ฿2.32b |
16.1x
P/E Ratio2.0x
P/S RatioIs PHG-R overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PHG-R income statement (TTM) | |
---|---|
Revenue | ฿2.32b |
Cost of Revenue | ฿1.72b |
Gross Profit | ฿593.31m |
Other Expenses | ฿298.54m |
Earnings | ฿294.77m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.98 |
Gross Margin | 25.62% |
Net Profit Margin | 12.73% |
Debt/Equity Ratio | 0% |
How did PHG-R perform over the long term?
See historical performance and comparison